TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
簡國龍Chien, Kuo-Liong
- 計畫主持人
- 執行臨床試驗年資 22 年 9 個月
-
klchien@ntu.edu.tw
發表文獻
111筆
21
SW Huang, CY Tsa, CS Tseng, MC Shih, YC Yeh, KL Chien, YS Pu, YK Tu: Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: A systematic review and network meta-analysis, BMJ, 2019;367:l5919. doi: 10.1136/bmj.l5919
22
Tsai WC, Wu HY, Peng YS, Hsu SP, Chiu YL9, Yang JY, Chen HY, Pai MF, Lin WY, Hung KY, Chu FY, Tsai SM, Chien KL. Short-Term Effects of Very-Low-Phosphate and Low-Phosphate Diets on Fibroblast Growth Factor 23 in Hemodialysis Patients: A Randomized Crossover Trial. Clin J Am Soc Nephrol. 2019;14(10):1475-1483.
23
TL Yeh, WT Lei, SJ Liu, KL Chien: A modest protective association between pet ownership and cardiovascular diseases: A systematic review and meta-analysis., PLoS ONE, 2019;14(5):e0216231
24
CT Chao, R Wang, KL Chien, D Chan: Frailty predicts an increased risk of end-stage renal disease with risk competition by mortality among 165,461 diabetic kidney disease patients, Aging and Disease, 2019;10(6):1270-1281.
25
Mandy, et al (KL Chien as a co-author). Associations of circulating very-long chain saturated fatty acids and incident type 2 diabetes: a pooled analysis of prospective cohort studies, Am J Clin Nutr 2019;109(4):1216-1223.
26
M Marklund, et al (KL Chien as a co-author): Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality: an individual-level pooled analysis of 30 cohort studies, Circulation, 2019;139(21):2422-2436.
27
TJ Liu, HC Tai, KL Chien, NC Cheng: Predisposing factors of necrotizing fasciitis with comparison to cellulitis in Taiwan: a nationwide population-based case-control study, Journal of the Formosan Medical Association, 2019; S0929-6646(18)30620-X.
28
Tsai, WC, KL Chien: Accuracy of a Nutrient Database in Estimating the Dietary Phosphorus-to-Protein Ratio and Using a Boiling Method in Low-Phosphate Hospital Diets, Scientific Reports, 2018;8(1):15246.
29
Chao CT, Wang J, Chien KL. Both pre-frailty and frailty increase healthcare utilization and adverse health outcomes in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2018;17(1):130.
30
CT Chao, R Wang, JW Huang, KL Chien: Acarbose use and liver injury in diabetic patients with severe renal insufficiency and hepatic diseases: A propensity score-matched cohort study, Frontiers in Pharmacology, section Gastrointestinal and Hepatic Pharmacology, 2018;9:860
